The European Health Data Space (EHDS) is moving from legislative blueprint to operational reality, and registry owners across Europe are beginning to feel the shift. For disease registries, device registries, and clinical quality registries, the ability to support cross-border regulatory approvals now depends on how well their data infrastructure aligns with EHDS technical and semantic requirements. This registry RWE compliance checklist is designed to help registry operators audit their data standards, close interoperability gaps, and position their real-world evidence as a trusted input for faster European regulatory decisions.
Why Registry RWE Is the Next Battleground for EHDS Readiness
Registries have always held unique value for regulators because they capture longitudinal, real-world data from routine clinical practice. What the EHDS changes is the scale: once fully implemented, it will create a seamless infrastructure for health data sharing across member states. Regulators such as the European Medicines Agency and national competent authorities will increasingly expect registry data to be FAIR — findable, accessible, interoperable, and reusable. Registries that do not adapt now risk being excluded from the very evidence pathways that will accelerate cross-border approvals in the coming years.
The EHDS Regulatory Landscape: What Registry Owners Need to Know
The EHDS regulation introduces distinct obligations for electronic health record systems, data quality, interoperability, and secondary use of data. For registry operators, the core implication is that a registry is no longer a standalone research asset — it is a potential source of regulatory-grade evidence that must conform to European data standards. Regulators are increasingly promoting a “one data, many uses” philosophy, where registry data is collected once and reused across multiple regulatory contexts. The practical consequence is that data governance, provenance, and quality frameworks must be embedded in registry operations from the start, not retrofitted at submission time.
The Registry RWE Compliance Checklist
Use this checklist as a practical audit tool. Each item addresses a specific dimension of EHDS alignment, and together they create a defensible foundation for regulatory submissions.
1. Map Your Data to the European Electronic Health Record Exchange Format
The EHDS mandates interoperability for electronic health records, and the European Electronic Health Record Exchange Format (EEHRxF) is the foundational technical standard. For registries, this means mapping core variables to FHIR resources and the relevant EU core datasets. Begin with a gap analysis that identifies which registry fields map cleanly to FHIR profiles and which require extensions. Special attention should be paid to identifiers: patient IDs, provider IDs, and organization IDs must be resolvable across national borders to enable meaningful cross-country analysis.
2. Establish Provenance and Lineage for Every Variable
When a regulator receives registry data, the first question is always: where did this data come from, who entered it, and what transformations were applied? The EHDS data quality framework places strong emphasis on traceability. Implement a provenance layer in your registry schema that records the source system, clinical context, timestamp, and any transformation logic for each data element. This is not merely a technical exercise — it is the foundation of regulatory trust. Without clear lineage, even high-quality data may be considered unusable for a marketing authorization review.
3. Implement a European-Wide Patient Consent and Opt-Out Framework
The EHDS gives citizens granular control over their health data, and registries operating across borders must be able to honor that control consistently. A modern consent management layer should support:
- granular consent for different categories of data
- cross-border opt-out signals that propagate across member states
- re-consent workflows when a new research purpose emerges
The binary “yes/no” consent model is no longer acceptable. Build a consent infrastructure that can process EHDS electronic consent forms and update all participating registries in near real time.
4. Align Your Vocabulary with a Common Data Model
Semantic interoperability requires shared vocabularies. The EHDS leans heavily on standard terminologies such as SNOMED CT, LOINC, and ATC. In practice, mapping registry variables to a common data model like OMOP is becoming the most pragmatic route for cross-border readiness. A common data model allows your registry to participate in distributed RWE networks, including the EMA’s DARWIN EU initiative, without requiring raw data to leave your jurisdiction. This is one of the strongest signals you can send to regulators that your data is ready for secondary use.
5. Build for Secondary Use: Quality, Representativeness, and Bias Checks
Registries are often designed to answer a single research question. The EHDS expands the scope to broader secondary use, which means regulators will scrutinize completeness of follow-up, missing data patterns, selection bias, and external validity. Implement a periodic data quality dashboard that tracks these metrics and produces a clear representativeness statement relative to your target population. When your data supports a cross-border approval, regulators will receive a quality narrative rather than a raw export — and that shortens the evaluation cycle considerably.
6. Address the EHDS Metadata Catalogue Requirements
The EHDS will establish a metadata catalogue for health data access, and registry owners need to be visible in it. Prepare a structured metadata record that describes your registry’s population, variables, structure, governance, and access conditions. Make it machine-readable and align it with HealthDCAT-AP, the recommended vocabulary for health data catalogues in Europe. This step is frequently underestimated, but it is the difference between being discoverable by regulators and researchers and being essentially invisible in the European data landscape.
7. Plan for Dynamic Data Sharing, Not Just Static Exports
The traditional registry data exchange model is a static export: a CSV file or SAS extract sent to a partner. The EHDS envisions a far more dynamic approach, including APIs, federated queries, and on-demand data access. Start building a secure FHIR-based API layer for your registry that exposes clean, versioned data. This positions your registry as a live component of the European health data infrastructure rather than a static repository. Dynamic access will become the norm for regulatory evaluation, and early adopters will be a step ahead.
How Following This Checklist Accelerates Cross-Border Approvals
The direct benefit of EHDS alignment is reduced regulatory friction. When a registry can demonstrate conformity with European data quality and interoperability standards, regulators receive a strong signal that the evidence is trustworthy. Initiatives like DARWIN EU and the HMA’s Real-World Evidence work plan explicitly favor data sources that are standardized, governed, and accessible through common models. A registry that meets these criteria can be analyzed remotely without transferring sensitive raw data, which resolves many privacy concerns and speeds the evidence generation process.
There is also a practical benefit when regulatory follow-up questions arrive. In a traditional setup, answering an additional analysis request can take weeks or months due to data sharing agreements and manual extraction. With dynamic data access in place, the same request can be fulfilled in days. Under the EHDS framework, established data-access pathways will replace one-off contractual arrangements, making the entire approval conversation faster and more iterative.
Practical Next Steps for Registry Operators
Start with a self-audit against this checklist. Not every registry will have the resources to address all seven items immediately, so prioritize based on how your data is used. If your registry is already part of regulatory submissions, focus first on provenance and vocabulary mapping. If you are designing a new registry, build EHDS interoperability in from the start. Consider participating in a European reference network or a data access pilot to test your readiness in a real-world setting. And reach out to your national competent authority to understand how EHDS data access will function in your specific jurisdiction.
Finally, treat EHDS alignment not as a compliance burden but as a strategic opportunity. The registries that meet these standards will become preferred partners for academic researchers, biopharma sponsors, and regulatory agencies seeking robust real-world evidence across Europe.
Conclusion
The EHDS is transforming European health data from a patchwork of national systems into a cohesive infrastructure. Registry owners who align their data standards with EHDS today will be positioned to support faster cross-border regulatory approvals and to extend their influence far beyond a single research question. The true shift is cultural: from isolated repositories to interconnected data sources that feed a European evidence ecosystem.
